Pictet Asset Management (UK)’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-150,743
Closed -$846K 1847
2021
Q1
$846K Sell
150,743
-14,144
-9% -$136K ﹤0.01% 1084
2020
Q4
$1.3M Hold
164,887
﹤0.01% 994
2020
Q3
$1.4M Sell
164,887
-10,001
-6% -$110K ﹤0.01% 931
2020
Q2
$1.82M Sell
174,888
-19,746
-10% -$186K ﹤0.01% 873
2020
Q1
$1.82M Buy
194,634
+137,124
+238% +$1.17M ﹤0.01% 861
2019
Q4
$461K Buy
+57,510
New +$1.41M ﹤0.01% 1042

Other funds holding WVE

Pictet Asset Management (UK)'s WVE Position: Q2 2021 in Review

Pictet Asset Management (UK) sold out of Wave Life Sciences (WVE) in Q2 2021, closing a stake of 150,743 shares — an estimated $846K sold.

Pictet Asset Management (UK) first reported a position in WVE in Q4 2019 and held it in 6 quarters. The position peaked at $1.82M in Q1 2020. 87 funds tracked by Wall St. Rank hold WVE as of Q2 2021.

  • Pictet Asset Management (UK) reported no remaining Wave Life Sciences position as of Q2 2021 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 150,743 Wave Life Sciences shares in Q2 2021, an estimated $846K.
  • Pictet Asset Management (UK) first reported a position in Wave Life Sciences in Q4 2019 and held it in 6 quarters.
  • Pictet Asset Management (UK)'s Wave Life Sciences position peaked at $1.82M in Q1 2020.
  • 87 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.